Document is current
Any future updates will be listed below
-
Authors
Ferguson, Fleur M. https://orcid.org/0000-0003-4091-7617
- License Information
-
More Information
Article History
First Online: 19 May 2022
Competing interests
: F.F. is a scientific co-founder and equity holder in Proximity Therapeutics, and a scientific advisory board member and equity holder in Triana Biomedicines. F.F. is or was recently a consultant or received speaking honoraria from RA Capital, Tocris BioTechne and Plexium Inc. The Ferguson lab receives or has received research funding from Ono Pharmaceutical Co. Ltd.
